Ann: Full Year Statutory Accounts, page-39

First 39 Last

Share
Profile

Follow
Somac

37 Posts.

1

11/10/18

09:20

Post #: 36078591
Share

Originally posted by Larkin ↑

From the Auditors report.

“Basis for qualified opinion A limitation in the scope of our audit work exists for the reasons described below:
Included within Notes 10 & 27 of the financial report, the Group has reported a loan receivable from AXIS Consultants Pty Ltd amounting to $13,752,125 (2017: $12,158,032) which has been fully provided for. We have been unable to obtain sufficient appropriate audit evidence in respect to the collectability or otherwise of this amount.
Included within Note 11 of the financial report, the Group has reported Inventory in relation to its diamond stock at an estimated realisable value of $637,717. We have been unable to obtain sufficient appropriate audit evidence in respect to the expected sale price of the diamond stock supporting its estimated realisable value as shown in the financial report. These uncertainties may require a further adjustment to the value of the diamond stock, should management achieve sales at materially different prices to those estimated. Furthermore, it was not feasible to observe the counting of physical inventories as at 30 June 2018 or satisfy ourselves concerning those inventory quantities of diamonds by alternative means.
Accordingly, we were unable to determine whether adjustments might have been necessary had these limitations in scope not existed.”

Expand

So this says that the Group (Merlin) has received from AXIS $13.752 million dollars?

WHAT IS GOING ON!!!!

Does Merlin OWE Axis 13 + Million dollars?

MED Price at posting: 0.6¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

HotCopper Highlights: Your most watched stocks for Week 48, 2024

ADD

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

RSG

Resolute shares bounce back as second payment made to Mali government to secure workers' release

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

There are more pages in this discussion • 78 more messages in this thread...

First 39 Last

Add MED (ASX) to my watchlist

Ann: Full Year Statutory Accounts, page-39

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

Resolute shares bounce back as second payment made to Mali government to secure workers' release

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects